Related content

Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell nonHodgkin's lymphoma: A prospective study of 46 cases

By            

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 695-700

Spandidos Publications

Access to resources Recommend Favorite

Significance of clinical factors as prognostic indicators for patients with peripheral Tcell nonHodgkin lymphoma: A retrospective analysis of 252 cases

By                          

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 911-917

Spandidos Publications

Access to resources Recommend Favorite

Immunogenicity of Influenza Vaccination in Patients with Non-Hodgkin Lymphoma

By Centkowski Piotr   Brydak Lidia   MachaŁa Magdalena   Kalinka-Warzocha Ewa   BŁAsiŃSka-Morawiec Maria   Federowicz Irena   Walewski Jan   Wc{E}? Joanna   WoŁOwiec Dariusz   Lech-MaraŃDa Ewa   Sawczuk-Chabin Joanna   BiliŃSki PrzemysŁAw   Warzocha Krzysztof  

Journal of Clinical Immunology, Vol. 27, Iss. 3, 2007-05 ,pp. : 339-346

Springer Publishing Company

Access to resources Recommend Favorite

Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin’s lymphoma patients

By Perrotti Alessio  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 493-494

Springer Publishing Company

Access to resources Recommend Favorite

Bendamustine for non-Hodgkin lymphoma

By Gribben John  

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 123-125

Informa Healthcare

Access to resources Recommend Favorite